NPC2 p.Thr44Pro
c.130A>C · rs2139670146 · VCV1769606
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3067 | likely benign |
|---|---|---|
| REVEL | 0.358 | indeterminate |
| SaProt | LLR -12.01 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 0.24 | GERP -1.7 |
| Regional constraint | o/e 0.91 | unconstrained · MANE · 13 kb · p 0.22 · regional, not allelic |
| Overall | ||
| CADD | 20.4 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- NPC2
- Protein
- p.Thr44Pro
- Coding
- c.130A>C
- MANE Select
- NM_006432
- dbSNP
- rs2139670146
- Type
- single nucleotide variant
- Location
- chr14:74486389 (GRCh38)
- Gene constraint
- LOEUF 1.422 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 92.88 · 2 PDB
Similar variants
- NPC2 p.Thr44Ile Uncertain significance ★ ⚠ same residue
- NPC2 p.Thr44= Likely benign ★ same residue
- NPC2 p.Cys47Ter Pathogenic ★★ same condition
- NPC2 p.Glu20Ter Pathogenic ★★ same condition
- NPC2 p.Asn98His Uncertain significance ★★ ⚠ same condition
- NPC2 p.Asp91Asn Uncertain significance ★★ ⚠ same condition
- NPC2 p.Gln102Arg Uncertain significance ★★ ⚠ same condition
- NPC2 p.Gln136Glu Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/npc2-p-thr44pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown